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ABSTRACT-Nucleoprotamines are a normal component of human sperm cells. Antibodies against 
these protamines develop in 22 to 33 per cent of patients undergoing elective vasectomy. These 
antibodies, in turn, have been shown to cross-react with medicinal protamines, which are extracted 
commercially from the testes of salmon and certain other fish. This cross-reactivity against pro- 
tamines raises the possibility that patients who have undergone elective vasectomy may be at in- 
creased risk of an allergic reaction developing if they are later exposed to protamine as a medica- 
tion. Since medicinal protamines currently enjoy widespread clinical use, this information should 
be borne in mind by those clinicians using protamine and by urologists when counselling patients 
concerning elective vasectomy for sterilization. 
Protamine is a widely used medication which is 
administered after certain procedures to reverse 
heparin-induced anticoagulation. One would 
hardly suspect that undergoing an elective vas- 
ectomy would place a patient at increased risk 
of a serious allergic reaction to this medication. 
Yet, a series of studies from the Netherlands1-3 
now provides substantial evidence that, for vas- 
ectomized patients, such risk may indeed ex- 
ist. The following case report is presented to 
bring further attention to this potential hazard. 
Presented at the 30th Annual Kimbrough Urological Seminar, 
New Orleans, Louisiana, November, 1982. 
*The opinions or assertions contained herein are the private 
views of the authors and are not to be construed as official or as 
reflecting the views of the Department of the Army or the Depart- 
ment of Defense. 
tRetired. 
Case Report 
In April, 1982, a forty-two-year-old man un- 
derwent cardiac catheterization for evaluation 
of coronary vessel disease. Within five minutes 
after receiving an intravenous injection of pro- 
tamine, pruritus and hives developed over his 
neck and face. There was no wheezing or 
change in blood pressure. The allergic reaction 
responded promptly to intravenous diphenhy- 
dramine hydrochloride (Benadryl). Several 
months later, at the termination of open heart 
surgery, protamine was again injected. To pre- 
vent another allergic reaction, methylpredniso- 
lone (Solu-Medrol) and 25 mg of diphenhy- 
dramine were injected first. The patient 
experienced no untoward reaction and has since 
done well. 
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FIGURE 1. Schematic drawing of structure pro- 
posed for protamine-herring protamine (clupeine) Y 
I. (From Ottensmeyer, Whiting, and Korn,‘Q repro- 
duced with permission.) 
This patient had previously undergone an 
elective vasectomy for sterilization in 1967 and 
had required repeat surgery for sperm granu- 
loma formation in 1975. In assessing the im- 
munologic consequences of the vasectomy, a 
tray agglutination test (TAT),4 a microimmobi- 
lization tesQ5 and an antiprotamine immuno- 
fluorescence tests were performed. While re- 
sults of the immobilization test were negative, 
the serum showed a sperm-agglutinating anti- 
body titer of 1:1024. And, when swollen sperm 
heads that had been treated with triton X-100 
detergent 1% and diothiothreitol (a reducing 
agent) were added to serum diluted 1:5 and 
1:20, to demonstrate the presence of antipro- 
tamine antibody, one of the most intense im- 
munofluorescent reactions ever recorded in this 
laboratory occurred. 
Comment 
Several factors point to a relationship be- 
tween this patient’s history of vasectomy and 
his subsequent allergic reaction to protamine. 
First, we do know that vasectomy can lead to 
formation of systemic antibodies. The studies of 
several investigator@ have shown that after va- 
sectomy, agglutinating antibodies against sper- 
matozoa develop in 60 per cent or more of the 
cases. Thus, men who have undergone a vasec- 
tomy are at risk of reacting to spermatozoa and 




FIGURE 2. Schematic representation of spiraling 
chain of protamine interfacing with DNA helix. 
(From Felix,e reproduced with permission.) 
Protamines are molecules of low molecular 
weight and consist chiefly of amino acids, most 
prominently arginine. The compound forms a 
helix, with arginine moieties facing away from 
the core (Fig. 1) .8-10 This configuration permits 
an intimate, spiraling interface with the nu- 
clear DNA moleculer” (Fig. 2). Protamines are 
related to nucleohistones. However, while nu- 
cleohistones are widely distributed throughout 
the animal kingdom, it is only in the developing 
spermatids that these nucleohistones are re- 
placed by nucleoprotamines.2 
The protamine used commercially for medi- 
cation is extracted from sperm cells within the 
testes of salmon and other fish. These pro- 
tamines are species specific, but there can be a 
strong crossover of antigenicity against the pro- 
tamines of other species. Since in our patient 
antibodies to the protamine of his own sperm 
cells as a result of elective vasectomy had al- 
ready developed, it would seem that subsequent 
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exposure to antigenically similar fish protamine 
triggered his allergic reaction. 
To substantiate this hazard, Samuel2 has un- 
dertaken direct immunofluorescence of the sera 
of 78 men who had undergone elective vasec- 
tomy; antibodies against protamine were un- 
covered in 17 of these patients (22 % ).’ In other 
related studies, antibodies against protamine 
after vasectomy have been detected in 30 per 
cent (of 47 patients)3 and 33 per cent (of 71 pa- 
tients) .7 The observations that these antibodies 
(1) developed progressively during the year af- 
ter vasectomy; (2) paralleled the development 
of antisperm agglutinating antibodies; and (3) 
were not found in prevasectomy samples, im- 
plicate vasectomy as the source of immunologic 
insult that stimulated antibody formation 
against protamine. 1.7 Patients in whom sperm 
granulomas develop postoperatively seem to be 
at increased risk.3 
If these antibodies against human protamine, 
developed as a result of elective vasectomy, 
truly increase the risk of an allergic reaction on 
subsequent exposure to medicinal protamine, 
the clinical consequences could prove substan- 
tial. For instance: (1) patients such as ours who 
have undergone elective vasectomy might be at 
higher risk of mild allergic reactions developing 
on later exposure to protamine as an antihep- 
arin agent; (2) more important, these patients 
might also be at higher risk of suffering an ana- 
phylactic reaction; and (3) since use of pro- 
tamine as a heparin antagonist is not limited to 
open heart surgery, patients exposed to pro- 
tamine in other cardiovascular surgery, in 
dialysis, and in many leukophoresis techniques 
would also be at higher risk of allergic reaction 
if they had undergone prior vasectomy. Even 
diabetic patients, following vasectomy, might 
react adversely to protamine zinc insulin. 
The exact mechanism by which antibody for- 
mation against protamine evolves is not well 
understood. Protamine itself does not appear to 
be antigenic; injections of purified protamines 
alone do not evoke an antibody response. How- 
ever, protamines in vivo are intimately bound 
to the DNA helix (Fig. 2). Thus it is possible 
that antibodies are not developed directly 
against protamine, but rather against the 
protamine/DNA complex. If this is the case, 
there may be a risk that in vasectomy patients 
antibodies will develop not only against pro- 
tamine, but also against the protamine/DNA 
complex, and, more specifically, against DNA 
itself. And, if this is the case, the potential con- 
sequences could be far more serious.‘.7 
Conclusion 
The exact clinical consequence of postvasec- 
tomy antibodies against protamine remains un- 
certain. However, it clearly has been shown 
that antibodies against human protamine do 
develop in 22 to 33 per cent of patients undergo- 
ing elective vasectomy, and that these anti- 
bodies do cross-react with fish protamines now 
widely used in clinical medicine. This informa- 
tion and the clinical concerns it raises should be 
borne in mind by clinicians who are using pro- 
tamine in their practice. The potential risk 
should also be kept in mind when urologists 
counsel their patients concerning elective vasec- 
tomy for sterilization. 
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